NP47923a Adalimumab, NP47923b Tocilizumab and NP47923c Eculizumab
Supply of adalimumab, tocilizumab and eculizumab to NHS Scotland.
Buyer
The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
Value
£92,000,000
Published
20 Oct 2023
Closes
21 Nov 2023
Procurement details
Source
Pcs
Region
United Kingdom
Procurement method
Open
Category
Goods
Contract starts
Not provided
Contract ends
Not provided
CPV classifications
33600000
Pharmaceutical products
Lots
Lot 3 NP47923c Eculizumab
£10,596,600
Supply of eculizumab vials to NHS Scotland. The Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of three (3) Framework Participants. This Lot will be awarded from 1 March 2024, for 24 months, with an expiry date of 28 February 2026. This Lot has the option to extend by any number of periods, up to the...
Delivery: Scotland
Lot 2 NP47923b Tocilizumab
£35,297,308
Supply of tocilizumab pre-filled pens/devices, pre-filled syringes and vials to NHS Scotland. The Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of three (3) Framework Participants. This Lot will be awarded from 1 March 2024, for 12 months, with an expiry date of 28 February 2025. This Lot has the op...
Delivery: Scotland
Lot 1 NP47923a Adalimumab
£48,121,224
Supply of Adalimumab pre-filled pens/devices and pre-filled syringes to NHS Scotland. The Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of six (6) Framework Participants. This Lot will be awarded from 1 March 2024, for 24 months, with an expiry date of 28 February 2026. This Lot has the option to ex...
Delivery: Scotland
Documents
Unlock document linkNP47923a Adalimumab, NP47923b Tocilizumab and NP47923c Eculizumab
Not provided
Supply of adalimumab, tocilizumab and eculizumab to NHS Scotland.
Contract notice · Web page
Contains public sector information licensed under the Open Government Licence v3.0.